| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) | 
|---|
| 10/21/2014 | US8865863 MCR dendrimers | 
| 10/21/2014 | US8865673 Monitoring and modulating HGF/HGFR activity | 
| 10/21/2014 | US8865672 Prevention of tissue ischemia and related methods | 
| 10/21/2014 | US8865663 Method for the administration of anti-cancer drugs | 
| 10/21/2014 | US8865648 Monomeric and dimeric forms of adiponectin receptor fragments and methods of use | 
| 10/21/2014 | US8865647 Pharmaceutical solution of non covalently bound albumin and acylated insulin | 
| 10/21/2014 | US8865644 Rapamycin formulation using recombinant high-density lipoprotein including apolipoprotein A-I and a mutant thereof | 
| 10/21/2014 | US8865643 Recombinant surfactant protein D compositions and methods of use thereof | 
| 10/21/2014 | US8865629 Library of translational fusion partners for producing recombinant proteins and translational fusion partners screened therefrom | 
| 10/21/2014 | US8865446 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same | 
| 10/21/2014 | US8865440 Microorganisms having enhanced resistance to acetate and methods of use | 
| 10/21/2014 | US8865429 Increased oil content by increasing Yap1 transcription factor activity in oleaginous yeasts | 
| 10/21/2014 | US8865428 Protein production method, fusion protein, and antiserum | 
| 10/21/2014 | US8865425 Reagent and reagent kit for measurement of FDP, and measurement method | 
| 10/21/2014 | US8865424 Anti-FDP monoclonal antibody, FDP measurement reagent and reagent kit using same, and FDP measurement method | 
| 10/21/2014 | US8865419 Method for the screening of conserved secreted proteins | 
| 10/21/2014 | US8865414 Detection conjugate and method for analysis | 
| 10/21/2014 | US8865347 Digital alloys and methods for forming the same | 
| 10/21/2014 | US8865188 Methods and compositions for controlling assembly of viral proteins | 
| 10/21/2014 | US8865186 Genetically engineered clostridial genes, proteins encoded by the engineered genes, and uses thereof | 
| 10/21/2014 | US8865185 Methods of use for HSV-1 and HSV-2 vaccines | 
| 10/21/2014 | US8865184 Vaccine for chikungunya virus infection | 
| 10/21/2014 | US8865179 Aptameric IgE peptides in a protein scaffold as an allergy vaccine | 
| 10/21/2014 | US8865176 Methods and compositions for generating bioactive assemblies of increased complexity and uses | 
| 10/21/2014 | US8865173 Treatments for pancreatic cancer metastases | 
| 10/21/2014 | US8865171 Soluble forms of Hendra and Nipah virus G glycoprotein | 
| 10/21/2014 | US8865168 Methods and compositions to regulate hepcidin expression | 
| 10/21/2014 | US8865166 Antibodies to IL-17A and uses thereof | 
| 10/21/2014 | US8865154 Recombinant factor VIII having enhanced stability following mutation at the A1-C2 domain interface | 
| 10/21/2014 | US8865153 Microorganisms for imaging and/or treatment of tumors | 
| 10/21/2014 | US8865124 Probe reagent for measuring oxidative stress | 
| 10/16/2014 | US20140309411 Therapeutic compositions | 
| 10/16/2014 | US20140309408 Method for purifying virus-like particles (vlp) | 
| 10/16/2014 | US20140309407 Derivatisation of Erythropoietin (EPO) | 
| 10/16/2014 | US20140309402 Msp nanopores and related methods | 
| 10/16/2014 | US20140309400 Use of Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway for the Treatment of Dry Eye Syndrome | 
| 10/16/2014 | US20140309292 Mutations of Histone Proteins Associated with Proliferative Disorders | 
| 10/16/2014 | US20140309291 Compositions and Methods for Increasing Stress Resilience | 
| 10/16/2014 | US20140309290 Method of gene transfer for the treatment of recessive catecholaminergic polymorphic ventricular tachycardia (cpvt) | 
| 10/16/2014 | US20140309176 Ethanol dependence of alpha1 antitrypsin c-terminal lys truncation by basic carboxypeptidases | 
| 10/16/2014 | US20140309175 Polymeric conjugates of c1-inhibitors | 
| 10/16/2014 | US20140309168 Modified peptides and proteins | 
| 10/16/2014 | US20140309166 Derivatisation of Erythropoietin (EPO) | 
| 10/16/2014 | US20140309163 Fibronectin based scaffold domain proteins that bind to myostatin | 
| 10/16/2014 | US20140309159 Compositions and methods for targeting nuclear import shuttles and treating inflammatory disorders | 
| 10/16/2014 | US20140309158 Compositions and methods for immunomodulation | 
| 10/16/2014 | US20140308746 Sustained polypeptide expression from synthetic, modified rnas and uses thereof | 
| 10/16/2014 | US20140308744 Compositions of Active WNT Protein | 
| 10/16/2014 | US20140308734 Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species | 
| 10/16/2014 | US20140308707 Method for production of factor viii | 
| 10/16/2014 | US20140308706 Recombinant fusion interferon for animals | 
| 10/16/2014 | US20140308520 Methods for the Bio-programmable Crystallization of Multi-component Functional Nanoparticle Systems | 
| 10/16/2014 | US20140308430 Effective use of yeast and yeast extract residue | 
| 10/16/2014 | US20140308318 Inhibitors against Endosomal/Lysosomal Enzymes | 
| 10/16/2014 | US20140308312 Use of micrornas to control virus helper nucleic acids | 
| 10/16/2014 | US20140308308 Compositions and methods for treatment of cytomegalovirus | 
| 10/16/2014 | US20140308307 Influenza A Virus Vaccines and Inhibitors | 
| 10/16/2014 | US20140308302 Anti-5t4 antibodies and uses thereof | 
| 10/16/2014 | US20140308300 Stabilized immune modulatory rna (simra) compounds for tlr7 and tlr8 | 
| 10/16/2014 | US20140308294 Anti-IL-1R1 Inhibitors For Use in Cancer | 
| 10/16/2014 | US20140308280 Factor VIII Polypeptide Formulations | 
| 10/16/2014 | US20140308264 VEGF Analogs and Methods of Use | 
| 10/16/2014 | US20140308262 Mitochondrial Proteins Constructs and Uses Thereof | 
| 10/16/2014 | US20140308259 Isolated b7-h4 specific compositions and methods of use thereof | 
| 10/16/2014 | US20140308209 Soluble Mediator | 
| 10/14/2014 | US8860979 Deletion of unwanted reply messages in e-mail printing | 
| 10/14/2014 | US8859852 Transformation of a plant to promote root and/or leaf growth | 
| 10/14/2014 | US8859851 Cold-tolerant plants expressing MYBS3 and DREB1A proteins | 
| 10/14/2014 | US8859747 Promoters exhibiting endothelial cell specificity and methods of using same | 
| 10/14/2014 | US8859745 Promoters exhibiting endothelial cell specificity and methods of using same | 
| 10/14/2014 | US8859735 Gelatin alkyd peptides and uses thereof | 
| 10/14/2014 | US8859733 Compositions and methods for promoting wound healing and tissue regeneration | 
| 10/14/2014 | US8859731 Selective modification of proteins | 
| 10/14/2014 | US8859730 Native chemical ligation at serine and threonine sites | 
| 10/14/2014 | US8859729 Growth hormone releasing peptides | 
| 10/14/2014 | US8859727 Bioactive FUS1 peptides and nanoparticle-polypeptide complexes | 
| 10/14/2014 | US8859725 Healthy kidney biomarkers | 
| 10/14/2014 | US8859724 Manufacture and use of modified polysaccharide chitosan bonds and a process to improve the preparation of HES-medicinal substance compounds | 
| 10/14/2014 | US8859722 Hemolysin and its protein fragments in sero-detection of anaplasma phagocytophilum | 
| 10/14/2014 | US8859537 Pharmaceutical composition for treating and/or preventing a pathology associated with an obsessional behavior or with obesity | 
| 10/14/2014 | US8859526 Methods for treating bleeding disorders using sulfated polysaccharides | 
| 10/14/2014 | US8859523 Crosslinked compounds and methods of making and using thereof | 
| 10/14/2014 | US8859520 Methods for therapy of neurodegenerative disease of the brain | 
| 10/14/2014 | US8859507 Protein complex for intracellular delivery and uses thereof | 
| 10/14/2014 | US8859505 Cysteine protease inhibitors | 
| 10/14/2014 | US8859500 Method for ameliorating pain by modification of NMDA receptors through inhibition of SRC | 
| 10/14/2014 | US8859499 Method of enhancing efficacy of blood transfusions | 
| 10/14/2014 | US8859498 Targeted therapeutic proteins | 
| 10/14/2014 | US8859497 Method of treatment using cysteine mutants of beta interferon | 
| 10/14/2014 | US8859495 Methods for stimulating or enhancing proliferation of non-tumorous cells expressing MUC1 receptors | 
| 10/14/2014 | US8859493 Insulin derivatives | 
| 10/14/2014 | US8859492 Metallodrugs having improved pharmacological properties, and methods of manufacture and use thereof | 
| 10/14/2014 | US8859491 Glucagon superfamily peptides exhibiting glucocorticoid receptor activity | 
| 10/14/2014 | US8859490 Peptide nucleic acid monomers and oligomers | 
| 10/14/2014 | US8859489 Water-mediated control of depolymerization step of glatiramer acetate synthesis | 
| 10/14/2014 | US8859488 Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response | 
| 10/14/2014 | US8859294 Method for binding a protein consisting of protein A or consisting of at least one domain of the A to E domains of the protein A to the substrate | 
| 10/14/2014 | US8859290 Inhibitors of influenza endonuclease activity and tools for their discovery | 
| 10/14/2014 | US8859284 Delivery of nanoparticles to neurons | 
| 10/14/2014 | US8859252 Prostatic acid phosphatase, compositions comprising the same, and methods for producing and/or purifying the same |